International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 604-608
Research Article
Comparison of Postoperative Bleeding Incidence in Laser Haemorrhoidoplasty with and without Hemorrhoidal Artery Ligation: A Prospective Observational Study
 ,
 ,
Received
Feb. 19, 2026
Accepted
March 2, 2026
Published
March 13, 2026
Abstract

Background: Laser Haemorrhoidoplasty (LHP) is a minimally invasive technique for treating symptomatic haemorrhoids. Hemorrhoidal Artery Ligation (HAL) targets vascular supply to reduce bleeding. This study compared postoperative bleeding incidence in patients undergoing LHP alone versus LHP combined with HAL.

Materials and Methods: This prospective observational study was conducted at SMS Medical College, Jaipur from 2024-2025. One hundred ten patients with Grade II-III haemorrhoids were randomized into two groups: Group A (LHP alone, n=55) and Group B (LHP+HAL, n=55). LHP was performed using 1470 nm diode laser with radial fiber delivery. In Group B, additional digital-guided HAL was performed using absorbable sutures. Postoperative bleeding was assessed using Verbal Rating Score (VRS) on Days 1, 3, 7, and 14. Secondary outcomes included pain (VAS), perianal swelling, hospital stay, and patient satisfaction.

Results: Both groups showed low postoperative bleeding rates with no significant difference. On Day 1, 94.5% (LHP) and 90.9% (LHP+HAL) had no bleeding (p=0.463). By Day 14, bleeding had nearly resolved in both groups (p=0.558). Mean pain scores were comparable (Day 1: 1.67±0.77 vs 1.96±0.88, p=0.068). Hospital stay averaged 1.04 days in both groups. Complete recovery at 6 weeks was 96.4% (LHP) and 100% (LHP+HAL). Patient satisfaction was high (4.53 vs 4.58 out of 5, p=0.690).

Conclusion: Both LHP alone and LHP with HAL are effective and well-tolerated for Grade II-III haemorrhoids. Adding HAL did not significantly reduce postoperative bleeding, suggesting LHP alone may be sufficient for most patients

Keywords
INTRODUCTION

Haemorrhoidal disease, commonly referred to as piles, is among the most frequently encountered anorectal disorders in surgical practice worldwide. It refers to the symptomatic enlargement and distal displacement of the anal cushions, which are normal anatomical structures involved in maintaining continence.1,2 Globally, the prevalence of hemorrhoidal disease ranges from 2.9% to over 50% depending on study design and population.3 In India, the burden is rising steadily, particularly in urban populations where low-fiber diets and sedentary habits are common.4,5

 

Traditional surgical options include Milligan-Morgan (open) and Ferguson (closed) haemorrhoidectomy, considered gold standards for Grades III and IV haemorrhoids.6 However, these are associated with significant postoperative pain (VAS scores 7-8/10), prolonged recovery, and complications such as bleeding, stricture, and incontinence.7 This has driven interest in less morbid alternatives.

Laser Haemorrhoidoplasty (LHP) using diode lasers (typically 1470 nm) delivers controlled thermal energy to coagulate and shrink haemorrhoidal tissue while preserving the anoderm.8 It offers advantages including minimal postoperative pain, shorter recovery, and day-case feasibility.9,10 Hemorrhoidal Artery Ligation (HAL) involves identifying and ligating terminal branches of the superior rectal artery, theoretically reducing vascular supply and bleeding risk.11

 

The rationale for combining LHP and HAL lies in complementary mechanisms—laser energy for tissue ablation and artery ligation for vascular control. This hybrid approach could theoretically reduce postoperative bleeding, a key concern following haemorrhoid surgery. However, evidence comparing these approaches remains limited. This study aimed to compare postoperative bleeding incidence in patients undergoing LHP alone versus LHP combined with HAL for Grade II-III haemorrhoids.

 

MATERIALS AND METHODS

Study Design and Setting

This prospective, hospital-based, observational comparative study was conducted at the Department of General Surgery, SMS Medical College and Attached Hospitals, Jaipur, Rajasthan, a tertiary care referral centre. The study was approved by the Institutional Ethics Committee and written informed consent was obtained from all participants.

 

Study Population and Sample Size

One hundred ten patients with Grade II or III internal haemorrhoids (Goligher classification) were enrolled. Sample size was calculated based on 80% power, 95% confidence level, and expected 25% difference in bleeding incidence, yielding 55 patients per group. Patients were randomized using simple chit-based method into Group A (LHP alone, n=55) and Group B (LHP+HAL, n=55).

 

Inclusion Criteria

  1. Age ≥18 years
  2. Diagnosed with Grade II or III internal haemorrhoids
  3. Willing to undergo laser haemorrhoidoplasty with or without artery ligation
  4. Provided written informed consent for participation

 

Exclusion Criteria

  1. Grade I or IV haemorrhoids
  2. Inflammatory Bowel Disease involving rectum and anal canal
  3. Acute thrombosed haemorrhoids
  4. Chronic liver disease, portal hypertension, or known coagulopathies
  5. History of prior surgical intervention for hemorrhoidal disease

 

Surgical Technique

Laser Haemorrhoidoplasty was performed using a 1470 nm diode laser with energy delivered intramucosally via radial fiber to coagulate the hemorrhoidal plexus. In Group B, additional digital-guided Hemorrhoidal Artery Ligation was performed using 2-0 absorbable sutures to ligate arterial branches supplying the haemorrhoids. All procedures were conducted by experienced colorectal surgeons under standardized anesthesia protocols.

 

Outcome Measures

The primary outcome was postoperative bleeding assessed using Verbal Rating Score (VRS: 0=no bleeding, 1=mild, 2=moderate, 3=severe) on Days 1, 3, 7, and 14. Secondary outcomes included pain (Visual Analog Scale 0-10), perianal swelling, hospital stay, readmission rate, recovery status at 6 weeks, and patient satisfaction score (1-5 scale).

 

Statistical Analysis

Data were analyzed using IBM SPSS version 26.0. Categorical variables were compared using Chi-square test; continuous variables using independent t-test or Mann-Whitney U test based on normality (Shapiro-Wilk test). p<0.05 was considered statistically significant.

 

RESULTS

One hundred ten patients completed the study with mean age of 46.65±13.07 years (LHP) and 47.40±13.93 years (LHP+HAL) (p=0.773). Males predominated in both groups (63.6% vs 67.3%, p=0.824). Baseline characteristics were comparable between groups (Table 1).

 

Table 1: Baseline Characteristics of Study Groups

Parameter

LHP (n=55)

LHP+HAL (n=55)

p-value

Age (years), Mean ± SD

46.65 ± 13.07

47.40 ± 13.93

0.773

Sex (Male/Female)

35/20

37/18

0.824

Grade II, n (%)

27 (49.1%)

25 (45.5%)

0.534

Grade III, n (%)

28 (50.9%)

30 (54.5%)

0.534

Symptom duration (months)

30.31 ± 16.43

32.31 ± 15.80

0.408

BMI (kg/m²)

26.01 ± 2.32

26.07 ± 2.78

0.891

LHP: Laser Haemorrhoidoplasty; HAL: Hemorrhoidal Artery Ligation; BMI: Body Mass Index

Postoperative Bleeding

Postoperative bleeding was low in both groups throughout follow-up. On Day 1, 94.5% of LHP and 90.9% of LHP+HAL patients had no bleeding (VRS=0). By Day 14, bleeding had nearly resolved with only 2 LHP and 1 LHP+HAL patients having mild bleeding (Table 2). No moderate or severe bleeding occurred on Days 1 or 14.

 

Table 2: Postoperative Bleeding (VRS) at Different Time Points

VRS

Day 1 LHP

Day 1 LHP+HAL

Day 7 LHP

Day 7 LHP+HAL

p-value

0 (None)

52 (94.5%)

50 (90.9%)

40 (72.7%)

45 (81.8%)

-

1 (Mild)

3 (5.5%)

5 (9.1%)

14 (25.5%)

6 (10.9%)

-

2 (Moderate)

0 (0%)

0 (0%)

1 (1.8%)

4 (7.3%)

-

p-value (Day)

-

0.463

-

0.071

-

VRS: Verbal Rating Score; Day 1 and Day 7 comparisons shown; Day 14: p=0.558

 

Figure 1: No Bleeding (VRS=0) Over Time

Figure 2: Pain Score (VAS) Over Time

 

Pain, Swelling, and Recovery Outcomes

Mean pain scores (VAS) were comparable between groups at all time points. On Day 1, VAS was 1.67±0.77 (LHP) versus 1.96±0.88 (LHP+HAL), p=0.068. By Day 14, both groups had minimal pain (0.07±0.26 vs 0.04±0.19, p=0.398). Perianal swelling was observed in 40.0% (LHP) and 38.2% (LHP+HAL) on Day 1 (p=0.845), resolving completely by Day 14 (Table 3).

 

Table 3: Pain (VAS) and Clinical Outcomes

Parameter

LHP (n=55)

LHP+HAL (n=55)

p-value

VAS Day 1

1.67 ± 0.77

1.96 ± 0.88

0.068

VAS Day 3

1.04 ± 0.77

1.00 ± 0.86

0.816

VAS Day 7

1.02 ± 0.76

1.00 ± 0.84

0.893

VAS Day 14

0.07 ± 0.26

0.04 ± 0.19

0.398

Perianal swelling Day 1

22 (40.0%)

21 (38.2%)

0.845

Hospital stay (days)

1.04 ± 0.19

1.05 ± 0.23

0.777

Readmission, n (%)

4 (7.3%)

3 (5.5%)

0.696

Complete recovery at 6 weeks

53 (96.4%)

55 (100%)

0.154

Satisfaction score (1-5)

4.53 ± 0.72

4.58 ± 0.60

0.690

VAS: Visual Analog Scale (0-10); Values are Mean ± SD or n (%)

Figure 3: Hospital Stay Distribution

Figure 4: Patient Satisfaction Score

 

DISCUSSION

This prospective observational study demonstrates that both Laser Haemorrhoidoplasty alone and LHP combined with Hemorrhoidal Artery Ligation are effective and well-tolerated techniques for Grade II-III haemorrhoids. Importantly, adding HAL to LHP did not significantly reduce postoperative bleeding at any time point, suggesting that LHP alone provides adequate hemostasis for most patients.

 

Our findings are consistent with the double-blinded RCT by Lim et al. (2022)12 who compared LHP alone versus LHP with HAL in 76 patients and found no significant difference in postoperative bleeding, perianal swelling, or pain. Similarly, De A. et al. (2021)13 reported excellent outcomes with hybrid HAL-LHP in 75 patients, with 72% achieving complete symptom resolution and zero recurrence at 6 months follow-up.

 

The low postoperative bleeding rates observed in our study (94.5% and 90.9% with no bleeding on Day 1) compare favorably with published literature. Brusciano et al. (2020)10 reported complication-free outcomes with 1470-nm diode laser in 50 patients, with minimal pain (VAS ~2) and no recurrence at 12 months. Longchamp et al. (2021)14 in their systematic review of 1,570 patients found pooled success rates of 90.7% for laser haemorrhoidoplasty.

 

The comparable pain scores between groups (VAS 1.67 vs 1.96 on Day 1) suggest that adding HAL does not increase postoperative discomfort. This is important as patient experience is a key consideration in minimally invasive surgery. Maloku et al. (2014)9 demonstrated that LHP produces significantly shorter operating times, less postoperative pain, and quicker return to daily activities compared to open haemorrhoidectomy.

 

Recent evidence supports the effectiveness of LHP across various settings. Chen et al. (2024)15 compared LHP with feeding vessel suture ligation versus Milligan-Morgan haemorrhoidectomy in 323 patients, finding significantly lower postoperative pain and shorter recovery with LHP. Jin et al. (2024)16 demonstrated superiority of LHP over rubber band ligation for Grade II haemorrhoids in terms of pain, bleeding, and recurrence rates.

 

The high patient satisfaction scores in both groups (4.53 and 4.58 out of 5) reflect the acceptability of laser-based treatments. Islam et al. (2024)17 reported 97.7% patient satisfaction with LHP in 86 patients with Grade II-IV haemorrhoids. Similarly, Tümer and Ağca (2023)18 found LHP resulted in significantly shorter hospital stay and quicker recovery compared to LigaSure haemorrhoidectomy.

 

The near-complete recovery at 6 weeks (96.4% LHP, 100% LHP+HAL) aligns with reports by Gupta et al. (2021)19 who found 94% symptom resolution with finger-guided HAL followed by LHP in 346 patients. The slightly higher complete recovery in the LHP+HAL group, though not statistically significant, may warrant further investigation in larger studies.

This study has several limitations. As a single-center study, results may not be generalizable. The 6-week follow-up may not capture long-term recurrence. Subjective assessment tools (VRS, VAS) introduce inherent variability. The lack of blinding may introduce observation bias. Additionally, cost-effectiveness was not analyzed, which is relevant in resource-limited settings.

 

CONCLUSION

Both Laser Haemorrhoidoplasty alone and LHP combined with Hemorrhoidal Artery Ligation are effective, safe, and well-tolerated techniques for Grade II-III haemorrhoids. Adding HAL to LHP did not significantly reduce postoperative bleeding, pain, or improve recovery outcomes. LHP alone may be sufficient for most patients, offering a simpler approach with equivalent efficacy. Larger multicenter trials with longer follow-up are warranted to confirm these findings and evaluate long-term recurrence rates.

 

CONFLICT OF INTEREST

The authors declare no conflicts of interest.

 

SOURCE OF FUNDING

This research received no specific grant from any funding agency.

 

REFERENCES

  1. Loder PB, Kamm MA, Nicholls RJ, Phillips RK. Haemorrhoids: pathology, pathophysiology and aetiology. Br J Surg. 1994;81(7):946-954.
  2. Pata F, Sgrò A, Ferrara F, Vigorita V, Gallo G. Anatomy, physiology and pathophysiology of haemorrhoids. Rev Recent Clin Trials. 2021;16(1):19-24.
  3. Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation: an epidemiologic study. Gastroenterology. 1990;98(2):380-386.
  4. Pillai C, Cross PK, Vinayakumar AR. Prevalence of hemorrhoids and related risk factors in Indian patients. Int Surg J. 2017;4(11):3641-3645.
  5. Mehta A, Jain N, Sharma M, Singh J. Pattern of proctologic disorders in North India. J Clin Diagn Res. 2016;10(8):PC01-PC03.
  6. Corman ML. Corman's Colon and Rectal Surgery. 6th ed. Lippincott Williams & Wilkins; 2012:884-893.
  7. Sun Z, Migaly J. Review of hemorrhoid disease: presentation and management. Clin Colon Rectal Surg. 2016;29(1):22-29.
  8. Abu Omar YAE, Al Ahmady RM. Laser Haemorrhoidectomy Versus Conventional Surgical Haemorrhoidectomy: Meta-Analysis. Ain Shams J Surg. 2024.
  9. Maloku H, Gashi Z, Lazovic R, Islami H, Juniku-Shkololli A. Laser Hemorrhoidoplasty vs Open Surgical Hemorrhoidectomy. Acta Inform Med. 2014;22(6):365-367.
  10. Brusciano L, Gambardella C, Terracciano G, et al. Postoperative discomfort and pain: laser hemorrhoidoplasty, a minimal invasive treatment. Lasers Med Sci. 2020;35(8):1797-1803.
  11. Scheyer M, Antonietti E, Rollinger G, Mall H, Arnold S. Doppler-guided hemorrhoidal artery ligation. Am J Surg. 2006;191(1):89-93.
  12. Lim SY, Rajandram R, Roslani AC. Comparison of post-operative bleeding incidence in laser hemorrhoidoplasty with and without hemorrhoidal artery ligation: RCT. BMC Surg. 2022;22(1):146.
  13. De A, Roy P. Hybrid digitally guided hemorrhoidal artery ligation with laser hemorrhoidoplasty. Int Surg J. 2021;8(10):2968-2973.
  14. Longchamp G, Liot E, Meyer J, et al. Non-excisional laser therapies for hemorrhoidal disease: systematic review. Lasers Med Sci. 2021;36(3):485-496.
  15. Chen KH, Huang YL, Lin CY, et al. Clinical outcomes of laser hemorrhoidoplasty with feeding vessels suture ligation. Tech Coloproctol. 2024;28(1):78.
  16. Jin L, Qin K, Wu R, et al. Laser hemorrhoidoplasty vs rubber band ligation for grade II hemorrhoids. BMC Surg. 2024;24(1):164.
  17. Islam MS, Shrestha AB, Chowdhury F, Ziko MRK. Outcomes of laser hemorrhoidoplasty for grade II-IV hemorrhoidal disease in Bangladesh. Ann Med Surg. 2024;86(11):6514-6520.
  18. Tümer H, Ağca MH. Comparing laser hemorrhoidoplasty and LigaSure hemorrhoidectomy in grade II-III hemorrhoids. ANZ J Surg. 2023;93(7-8):1885-1889.
  19. Gupta K, Agarwal N, Mital K. Clinical outcomes in patients treated by finger-guided hemorrhoidal artery ligation with laser hemorrhoidoplasty. JAMMR. 2021;33(18):143-152.
  20. De Nardi P, Maggi G, Pagnanelli M, Vlasakov I, Corbetta D. Hemorrhoid laser dearterialization: systematic review and meta-analysis. Lasers Med Sci. 2023;38(1):54
Recommended Articles
Research Article Open Access
Assessment Of Knowledge, Attitude and Practice on Chronopharmacology Among the Clinical Doctors in A Tertiary Care Hospital – A Cross-Sectional Study
2026, Volume-7, Issue 2 : 650-656
Research Article Open Access
A Study of Clinical Profile and Outcome of Bronchiolitis in Children of Age 1–24 Months at A Tertiary Care Hospital in South India
2026, Volume-7, Issue 2 : 557-564
Case Report Open Access
Bullet, Blood and Airway – Gun Shot Wound Face Managed with Limited Resources
2026, Volume-7, Issue 2 : 592-596
Original Article Open Access
Morphological and Anatomical Variations of the Coronary Arteries: A Cadaveric Study
2026, Volume-7, Issue 1 : 3161-3166
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
16 Views
33 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved